SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Mark Andrew Hlatky · Study

Home/Author

Mark Andrew Hlatky

15 works· latest 2021· 4 institutionscluster: provisionalORCID 0000-0003-4686-9441

h-index14

i1014

Citations2,535

Works here15

96

01

02

03

05

06

11

14

15

17

19

21

Most cited in this library

Increasing value and reducing waste in research design, conduct, and analysis2014 · 1,597 citations
Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association2017 · 286 citations
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I2002 · 128 citations
Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus2005 · 93 citations
Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events2019 · 79 citations

Works

15 shown

Socioeconomic position and first-time major cardiovascular event in patients with type 2 diabetes: a Danish nationwide cohort study

European Journal of Preventive Cardiology·2021·15 authors·Open access

17citations

Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events

JAMA Cardiology·2019·8 authors·Open access

79citations

Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association

Circulation·2017·12 authors·review·Open access

286citations

Women in Cardiology

Journal of the American College of Cardiology·2015·2 authors·editorial·Open access

18citations

Increasing value and reducing waste in research design, conduct, and analysis

The Lancet·2014·8 authors·Open access

1,597

citations

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

European Journal of Epidemiology·2011·25 authors·Open access

17citations

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration

Journal of Clinical Epidemiology·2011·25 authors·Open access

9citations

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

European Journal of Human Genetics·2011·25 authors·Open access

34citations

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

European Journal of Clinical Investigation·2011·25 authors

44citations

Cost-effectiveness as an outcome in randomized clinical trials

Clinical Trials·2006·3 authors

53citations

Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus

American Heart Journal·2005·15 authors

93citations

Quality of life and time trade-off utility measures in patients with coronary artery disease

American Heart Journal·2003·3 authors

57citations

Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I

Circulation·2002·2 authors

128citations

Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction

Annals of Internal Medicine·2001·7 authors

79citations

Growing pains of meta-analysis

BMJ·1996·2 authors·editorial·Open access

24citations